SLC2A4 and diabetic kidney disease: For example, miR-93-5p has been suggested to negatively regulate GLUT4 expression in kidney and fat cell lines [24], and miR-152-3p plasma levels were associated with development of diabetic nephropathy in individuals with T2D [25].